RxDoctor Payments Data

Michael Stevens

Family Medicine · North Las Vegas, NVNPI 1285106070

Payments from drug & device makers

$2,790in general payments, 2019–2025

Across 102 payments — averaging $27.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biohaven Pharmaceuticals, Inc.$865
  • AstraZeneca$653
  • Boehringer Ingelheim$322
  • Johnson & Johnson$125
  • Pfizer$90
  • AbbVie$89
  • plus $647 from 20 others

What the payments were for

  • Consulting fees$80029%
  • Food & beverage$1,99071%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,790 in reported general payments places this provider in the 80th percentile of 902 family medicine providers in Nevada.

See all family medicine providers in Nevada

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide14$20,051
JardianceEmpagliflozin13$13,645
Albuterol Sulfate HfaAlbuterol Sulfate22$846
Atorvastatin Calcium68$732
Levothyroxine Sodium25$311
Losartan Potassium22$258
Metoprolol Succinate19$235
Fluticasone Propionate11$211
Tamsulosin Hcl11$208
Metformin Hcl32$165
Omeprazole21$138
Gabapentin16$136
Ibuprofen17$124
Lisinopril22$112
Rosuvastatin Calcium17$111

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$63$20,05114 claims
Boehringer IngelheimJardiance$322$13,64513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 902 family medicine providers in Nevada.

Other family medicine in North Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →